Apigenin and Neuroprotection: What Preclinical Research Shows About Brain Health
Evidence-based overview of apigenin neuroprotection: antioxidant, anti-inflammatory, and amyloid-modulating effects found in preclinical brain research.
Evidence-based overview of apigenin neuroprotection: antioxidant, anti-inflammatory, and amyloid-modulating effects found in preclinical brain research.
Apigenin may support NAD+ levels by inhibiting CD38, an enzyme that depletes NAD+ faster as we age. Here is what current preclinical research shows.
Apigenin may support gut health by modulating microbiota composition, reinforcing intestinal barrier integrity, and reducing gut inflammation. Here’s what the r
An evidence-based look at how apigenin may support memory, reduce neuroinflammation, and influence mood through BDNF, CREB, and serotonin pathways.
Apigenin, a flavonoid in chamomile and celery, shows early promise for blood pressure and endothelial function. Here’s what the evidence actually shows.
A research-backed look at how apigenin, a plant flavonoid found in chamomile, may influence cancer cell behavior through multiple biological pathways.
A plain-language review of preclinical cell studies on apigenin and breast cancer, covering apoptosis, estrogen receptor effects, and honest study limitations.
Apigenin may ease anxiety by binding GABA-A receptors. Review the preclinical science, human dietary data, supplement considerations, and safety caveats.
How apigenin suppresses NF-κB, inhibits COX-2, and modulates MAPK signaling: an evidence-based look at its anti-inflammatory mechanisms.
Explore how the flavonoid apigenin may influence cellular senescence, autophagy, and sirtuin pathways, and what the current evidence actually supports.